Skip to main content

BRIEF-Akers Biosciences reports 10 pct fall in Q1 revenue

* Akers Biosciences Inc - expect to see growth in flagship pifa heparin pf/4 rapid assay product line for the year Source text for Eikon: Further company coverage:
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.